Characterization of Staphylococcus aureus isolates from pediatric patients with cystic fibrosis

World Journal of Microbiology and Biotechnology

Volumn 32, Issue 10, 2016, Pages

  Liu, Ying ^a,b   Zhang, Jiang ^a   Zhong, Dengke ^a,b   Ji, Lu ^b,c   Yang, Junshu ^b   Phillips, James ^c,d   Ji, Yinduo ^b  

^a Shanghai Vocational College of Agriculture and Forestry   (China)

^b UNIVERSITY OF MINNESOTA   (United States)

^c MAYO CLINIC   (United States)

^d GEORGETOWN UNIVERSITY   (United States)

Author keywords

Cystic fibrosis; Cytotoxicity; Invasion; MLST; Staphylococcus aureus

Indexed keywords

ABILITY TESTING; ANTIBIOTICS; BACTERIA; CELL CULTURE;

ANTIBIOTIC SUSCEPTIBILITIES; CYSTIC FIBROSIS; CYTOTOXIC ACTIVITIES; EPITHELIAL CELLS; INVASION; MLST; PEDIATRIC PATIENTS; STAPHYLOCOCCUS AUREUS;

CYTOTOXICITY;

ENTEROTOXIN;

A-549 CELL LINE; CELL SURVIVAL; CHILD; CYSTIC FIBROSIS; DRUG EFFECTS; GENETICS; HUMAN; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MULTILOCUS SEQUENCE TYPING; PENICILLIN RESISTANCE; PHYLOGENY; PROCEDURES; SPUTUM; STAPHYLOCOCCUS AUREUS;

A549 CELLS; CELL SURVIVAL; CHILD; CYSTIC FIBROSIS; ENTEROTOXINS; HUMANS; MICROBIAL SENSITIVITY TESTS; MULTILOCUS SEQUENCE TYPING; PENICILLIN RESISTANCE; PHYLOGENY; SPUTUM; STAPHYLOCOCCUS AUREUS;

EID: 84983606250     PISSN: 09593993     EISSN: 15730972     Source Type: Journal    
DOI: 10.1007/s11274-016-2122-4     Document Type: Article

References (38)

1. Agerer F, Michel A, Ohlsen K, Hauck CR (2003) Integrin-mediated invasion of Staphylococcus aureus into human cells requires Src family protein-tyrosine kinases. J Biol Chem 278:42524–42531
2. Andersen DH (1949) The present diagnosis and therapy of cystic fibrosis of the pancreas. Proc R Soc Med 42:25–32
3. Anderson MJ, Lin YC, Gillman AN, Parks PJ, Schlievert PM, Peterson ML (2012) Alpha-toxin promotes Staphylococcus aureus mucosal biofilm formation. Front Cell Infect Microbiol 2:64
4. Boucher RC (2007) Airway surface dehydration in cystic fibrosis: pathogenesis and therapy. Annu Rev Med 58:157–170
5. Bubeck Wardenburg J, Schneewind O (2008) Vaccine protection against Staphylococcus aureus pneumonia. J Exp Med 205:287–294
6. Bubeck Wardenburg J, Bae T, Otto M et al (2007a) Poring over pores: alpha-hemolysin and panton-valentine leukocidin in Staphylococcus aureus pneumonia. Nat Med 13:1405–1406
7. Bubeck Wardenburg J, Patel RJ, Schneewind O (2007b) Surface proteins and exotoxins are required for the pathogenesis of Staphylococcus aureus pneumonia. Infect Immun 75:1040–1044
8. Clarke SR, Foster SJ (2006) Surface adhesins of Staphylococcus aureus. Adv Microb Physiol 51:187–224
9. Emerson J, McNamara S, Buccat A, Worrell K, Burns JL (2010) Changes in cystic fibrosis sputum microbiology in the United States between 1995 and 2008. Pediatr Pulmonol 45:363–370
10. Enright MC, Day NP, Davies CE, Peacock SJ, Spratt BG (2000) Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus. J Clin Microbiol 38(3):1008–1015
11. Ericsson A, Granstrom M, Mollby R, Strandvik B (1986) Antibodies to staphylococcal teichoic acid and alpha toxin in patients with cystic fibrosis. Acta Paediatr Scand 75(1):139–144
12. Foster TJ, Höök M (1998) Surface protein adhesins of Staphylococcus aureus. Trends Microbiol 6:484–488
13. Iandolo JJ (1990) The genetics of staphylococcal toxins and virulence factors. In: Iglewski BH, Clark VL (eds) Molecular basis of bacterial pathogenesis. Academic Press, New York, pp 399–426
14. Koulenti D, Lisboa T, Brun-Buisson C, Krueger W, Macor A, Sole-Violan J, Diaz E, Topeli A et al (2009) Spectrum of practice in the diagnosis of nosocomial pneumonia in patients requiring mechanical ventilation in European intensive care units. Crit Care Med 37(8):2360–2368
15. Liang X, Ji Y (2007) Involvement of alpha5beta1-integrin and TNF-alpha in Staphylococcus aureus alpha-toxin-induced death of epithelial cells. Cell Microbiol 9:1809–1821
16. Liang X, Yu C, Sun J, Liu H, Landwehr C et al (2006) Inactivation of a two-component signal transduction system, SaeRS, eliminates adherence and attenuates virulence of Staphylococcus aureus. Infect Immun 74:4655–4665
17. Lina G, Piemont Y, Godail-Gamot F (1999) Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis 29:1128–1132
18. Lipuma JJ (2010) The changing microbial epidemiology in cystic fibrosis. Clin Microbiol Rev 23:299–323
19. Liu Y, Ji L, Yang J, Zhong D, Zhang J, Phillips J, Ji Y (2016) unpublished data
20. Lyczak JB, Cannon CL, Pier GB (2002) Lung infections associated with cystic fibrosis. Clin Microbiol Rev 15:194–222
21. McCormick JK, Yarwood JM, Schlievert PM (2001) Toxic shock syndrome and bacterial superantigens: an update. Annu Rev Microbiol 55:77–104
22. Menzies BE, Kourteva I (2000) Staphylococcus aureus α-toxin induces apoptosis in endothelial cells. FEMS Immunol Med Microbiol 29:39–45
23. Monday SR, Bohach GA (1999) Use of multiplex PCR to detect classical and newly described pyrogenic toxin genes in staphylococcal isolates. J Clin Microbiol 37:3411–3414
24. Naimi TS, LeDell KH, Como-Sabetti K (2003) Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA 290:2976–2984
25. Nimmo GR, Pearson JC, Collignon PJ, Christiansen KJ, Coombs GW, Bell JM, McLaws M-L, Resistance AGOA (2011) Antimicrobial susceptibility of Staphylococcus aureus isolated from hospital inpatients, 2009: report from the Australian group on antimicrobial resistance. Commun Dis Intell 35(3):237–243
26. O’Sullivan BP, Freedman SD (2009) Cystic fibrosis. Lancet 373:1891–1904
27. Ormerod K, George N, Fraser J, Wainwright C, Hugenholtz P (2015) Comparative genomics of non-pseudomonal bacterial species colonising paediatric cystic fibrosis patients. PeerJ 3:e1223. doi:10.7717/peerj.1223
28. Otto M (2014) Staphylococcus aureus toxins. Curr Opin Microbiol 17:32–37
29. Phillips J, Tripp T, Jones G, Regelmann W, Schlievert P, Wangensteen O (2006) Staphylococcal α-toxin causes increased tracheal epithelial permeability. Pediatr Pulmonol 41:1146–1152
30. Riordan JR, Rommens JM, Kerem B, Alon N, Rozmahel R, Grzelczak Z et al (1989) Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 245:1066–1073
31. Sagel SD, Gibson RL, Emerson J, McNamara S, Burns JL, Wagener JS, Ramsey BW (2009) Impact of Pseudomonas and Staphylococcus infection on inflammation and clinical status in young children with cystic fibrosis. J Pediatr 154(2):183–188
32. Saunders NA, Holmes A (2014) Multilocus sequence typing (MLST) of Staphylococcus aureus. Methods Mol Biol 1085:113–130. doi:10.1007/978-1-62703-664-1_7
33. Seeger W, Birkemeyer RG, Ermert L, Suttorp N, Bhakdi S, Duncker HR (1990) Staphylococcal alpha-toxin-induced vascular leakage in isolated perfused rabbit lungs. Lab Invest 63(3):341–349
34. Sibbald MJ, Ziebandt AK, Engelmann S et al (2006) Mapping the pathways to staphylococcal pathogenesis by comparative secretomics. Microbiol Mol Biol Rev 70:755–788
35. Vu-Thien H, Hormigos K, Corbineau G, Fauroux B, Corvol H, Moissenet D, Vergnaud G, Pourcel C (2010) Longitudinal survey of Staphylococcus aureus in cystic fibrosis patients using a multiple-locus variable-number of tandem-repeats analysis method. BMC Microbiol 10(1):24. doi:10.1186/1471-2180-10-24
36. Wilke G, Bubeck Wardenburg J (2010) Role of a disintegrin and metalloprotease 10 in Staphylococcus aureus α-hemolysin-mediated cellular injury. Proc Natl Acad Sci USA 107:13473–13478
37. Yagci S, Hascelik G, Dogru D, Ozcelik U, Sener B (2011) Prevalence and genetic diversity of Staphylococcus aureus small-colony variants in cystic fibrosis patients. Clin Microbiol Infect 19:77–84
38. Yang J, Ji Y (2014) Investigation of Staphylococcus aureus adhesion and invasion of host cells. Methods Mol Biol 1085:187–194. doi:10.1007/978-1-62703-664-1_11